Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Elite Health Systems (EHSI) Change in Receivables (2016 - 2021)

Elite Health Systems' Change in Receivables history spans 12 years, with the latest figure at -$828000.0 for Q2 2021.

  • Quarterly results put Change in Receivables at -$828000.0 for Q2 2021, down 407.98% from a year ago — trailing twelve months through Mar 2022 was -$828000.0 (down 291.67% YoY), and the annual figure for FY2025 was -$58000.0, changed.
  • Change in Receivables for Q2 2021 was -$828000.0 at Elite Health Systems, down from $482000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $660000.0 in Q4 2017 to a low of -$828000.0 in Q2 2021.
  • The 5-year median for Change in Receivables is -$85500.0 (2017), against an average of -$49500.0.
  • The sharpest move saw Change in Receivables crashed 468.63% in 2017, then surged 1216.67% in 2019.
  • Year by year, Change in Receivables stood at $660000.0 in 2017, then tumbled by 106.21% to -$41000.0 in 2018, then surged by 424.39% to $133000.0 in 2019, then crashed by 99.25% to $1000.0 in 2020, then crashed by 82900.0% to -$828000.0 in 2021.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$828000.0, $482000.0, and $1000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.